Penserra Capital Management LLC Krystal Biotech, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$39.81 - $88.24 $20,303 - $45,002	-510 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $260 - $358	5 Added 0.99%	510 $26,000
Q2 2021 Aug 12, 2021	BUY	$62.14 - $81.82 $310 - $409	5 Added 1.0%	505 $34,000
Q1 2021 May 13, 2021	BUY	$59.42 - $85.46 $2,971 - $4,273	50 Added 11.11%	500 $38,000
Q4 2020 Feb 12, 2021	BUY	$40.64 - $61.38 $18,288 - $27,621	450 New	450 $27,000

311

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.05B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.